SUBSCRIBE
SUBSCRIBE
News   FDA

Japan Approves Eisai Company, Ltd.'s Drug Aricept for Severe Alzheimer’s

August 23, 2007 | 
1 min read
TOKYO, Aug 23 (Reuters) - Eisai Co Ltd said on Thursday its top-selling Alzheimer's drug Aricept has been approved to treat the late stage of the disease in Japan, the world's second-biggest drug market.
FDA Approvals Asia
MORE ON THIS TOPIC
USA Flag formed by COVID-19 vaccine and blood test vials, 2019 pandemic United States of America, concept patriotic fighting coronavirus response, 3d illustration
FDA
‘Make American Healthy Again’ Report Takes Aim at Pharma Lobbying, GLP-1s and Vaccines
May 23, 2025
 · 
4 min read
 · 
Annalee Armstrong
Poznan, Poland - 5 October 2024: GSK -Glaxosmithkline headquarters office building in Poznan.
Immunology and inflammation
GSK Wins COPD Expansion for Nucala After FDA Delay
May 23, 2025
 · 
1 min read
 · 
Tristan Manalac
Syringe resting on top of a vaccine vial, with more vaccine bottles in the background
Vaccines
FDA Vaccine Advisors Agree on COVID-19 Vaccine as New Framework Looms as ‘Elephant in the Room’
May 23, 2025
 · 
2 min read
 · 
Tristan Manalac
Canada US crisis concept as a Broken Rope stretched with force and stressed to a decoupling metaphor for pressure on the economic and political relationship between Ottawa and Washington.
Drug pricing
FDA Advances Drug Importation Plan as Canada Moves To Protect Its Supply
May 22, 2025
 · 
2 min read
 · 
Annalee Armstrong